Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Intuitive Surgical (ISRG) through the VizualStocks API.
Count of da Vinci procedures performed reported by Intuitive Surgical during the period. This is activity over the reporting period rather than a period-end population.
daVinciProceduresPerformedPeriod-end count of da Vinci systems installed reported by Intuitive Surgical. This is a point-in-time population rather than activity during the period.
daVinciSystemsInstalledBaseRevenue from the limited-use instruments and accessories consumed in da Vinci surgeries and Ion bronchoscopy procedures. Because these products wear out or expire and must be replaced, the line scales mainly with procedure volume and is recurring rather than a one-time system sale.
instrumentsAndAccessoriesRevenueNumber of procedures performed with Intuitive's Ion robotic-assisted bronchoscopy platform, whose initial cleared use is minimally invasive lung biopsy. It measures utilization during the period, not the installed system population.
ionProceduresPerformedNumber of Ion robotic bronchoscopy systems newly placed with customers through sales or lease arrangements during the period. Placements measure quarterly commercial activity rather than the total Ion installed base.
ionSystemPlacementsRevenue from da Vinci and Ion systems placed under fixed-payment or usage-based operating leases. Fixed payments are recognized over the lease term, while usage-based revenue is recognized as customers perform procedures.
operatingLeaseRevenueRevenue generated outside the United States from Intuitive's instruments and accessories, da Vinci and Ion systems, and service contracts. It is a geographic total across revenue types rather than a separate product line.
outsideUnitedStatesRevenueGross profit from Intuitive's system placements and sales of limited-use instruments and accessories, calculated as product revenue less product cost of revenue. Service-contract economics are reported separately.
productGrossProfitRevenue from Intuitive's da Vinci and Ion systems plus the instruments and accessories used with them. It combines capital-equipment and procedure-driven consumable revenue but excludes service-contract revenue.
productRevenueGross profit from maintaining and supporting installed da Vinci and Ion systems, calculated as service revenue less service cost of revenue. It reflects the economics of Intuitive's service contracts rather than system or consumable sales.
servicesGrossProfitRevenue from service contracts that maintain and support Intuitive's installed da Vinci and Ion systems. The line is recurring and generally grows with the number and mix of systems in use.
servicesRevenueRevenue from placing da Vinci surgical systems and Ion robotic bronchoscopy systems through sales, sales-type leases and operating leases, including lease buyouts. Its quarterly level depends on placement volume, product mix, selling prices and the share of systems leased rather than sold.
systemsRevenueNumber of da Vinci surgical systems newly placed with customers during the period through outright sales, sales-type leases or fixed- and usage-based operating leases. It is a flow of new placements, not the period-end installed base.
totalDaVinciUnitPlacementsRevenue from instruments and accessories, service contracts and operating lease arrangements across Intuitive's da Vinci and Ion platforms. Intuitive uses it to assess the strength, utilization and procedure adoption of its installed base.
totalRecurringRevenueRevenue generated in the United States from Intuitive's instruments and accessories, da Vinci and Ion systems, and service contracts. It is a geographic total across revenue types rather than a separate product line.
unitedStatesRevenue